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Antibodies against the globular domain of histones Hl” and H5 were developed in rabbit. The antibody 
against the globular domain of H5 cross-reacted with Hl” but not with Hl; the antibody against the 
globular domain of Hl” did not cross-react with H5, Hl or with HMG proteins. The globular domain 
of Hi” therefore appears to have an immunologist determinant(s) which does not exist in HI and HS. 
By use of these antibodies, we show that nucleated erythrocytes of bullfrog contain an Hl”-like protein 
(not an HS-like protein). This observation coincided with the report of Shimada, T. et al. [J. Biol. Chem. 
256 (1981) 10577-105821. These antibodies have application in detecting Hl”-like proteins in eukaryotic 
cells. 
1. INTRODUCTION 
Very lysine rich histones have been implicated in 
the stabilization of higher order chromatin struc- 
tures f2], in the processes of chromosome conden- 
sation, cell division and transcriptions activity 
[2-S]. In the current model of the nucleosome 
[6,7] the central globular domain of histone Hl is 
Iocated at the DNA entry and exit points of the two 
turns of DNA [2,8]. One of the subfractions of the 
class of Hl histones called Hl’ [9] has been in- 
verse& correlated with mitotic activity [lo]. It is of 
particular interest hat the central globular domain 
of mammalian Hl” has considerable sequence 
homology with the same domain of the very lysine 
rich histone HS. H5 is found in the nucleated 
erythrocyte of birds Ill], reptiles [12], amphibians 
[13] and fish [13] and is thought to be involved in 
the terminal differentiation of erythrocytes. The 
sequence homology of these central domains of 
Hl D and H5 also results in very similar conforma- 
tions [IO] and in immunologic~ cross-reactivity 
[15,16]. The early report that bullfrog erythrocytes 
contain histone H5 ff3] has been questioned by a 
recent report of the presence of an Hl”-like pro- 
tein rather than H5 [l]. Methods are therefore re- 
quired to distinguish Hi” from H5 to clarify this 
situation and also to identify H1” histone in cells 
and tissues. 
2. MATERIALS AND METHODS 
2.1. Antigens and antisera 
Histones Hl and Hi ’ were prepared from beef 
liver as in [ 171. Histone H5 was prepared from 
chicken er~hroc~e as in 1181. Globular parts of 
Hl”, Hl and H.5 were prepared by trypsin diges- 
tion as in [10,19,20] in the presence of 1.0 M 
sodium chloride and purified by Sephadex G-50. 
Antisera against globular H5 and globule Hl’ 
were obtained from rabbits immunized every two 
weeks with 1OOpg protein-complete Freund’s ad- 
juvant (Difco) (1: 1, v/v). After the second injec- 
tion, the titer against each protein was observed, 
The sera used here were obtained after the fourth 
injection. 
2.2. E~ectr~p~~r~ti~ ransfer of pyotei~~ and 
immunoblotting 
Abbreviations: GHl, GHI O, GH5, globular Hl, HI” Proteins were electrophoresed by the use of 15% 
and H5 or 17.5% acrylamide gel containing SDS as in [21]. 
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The transfer of the proteins from SDS gels to 
nitrocellulose filter (Bio Rad) and immunoblotting 
were performed essentially as in [22]. 
2.3. Isolation of histones from bullfrog 
The erythrocytes were obtained by heart punc- 
ture from bullfrog, Rana catesbeiana. The nuclei 
were isolated from erythrocytes of bullfrog or 
chicken by use of saponin as in [23]. After isola- 
tion of crude nuclei, acid soluble nuclear proteins 
were extracted by 0.4 N sulfuric acid, precipitated 
by 25% trichloroacetic acid and washed with 
acidified acetone and acetone. 
3. RESULTS AND DISCUSSION 
3.1. Immunoassay of 
separated histones 
electrophoretically 
The globular part of Hl’ (GHl “) was highly im- 
munogenic as also reported for the globular part of 
HS (GH5) [16]. Lamb thymus core histones, 
globular domains of Hl ’ , HS, Hl , and total 
molecules of Hl, Hl” and H5 were transferred to 
nitrocellulose filter and checked for cross- 
reactivity against anti-GH lo or antiGH5. Fig. 1 
shows that anti-GH5 serum cross-reacts with H5, 
H lo and GHl ’ but does not cross-react with Hl , 
GHl and core histones (fig.2). GH5 therefore has 
some immunological determinants in common 
with GH lo. This result agrees with [ 15,161, In con- 
trast, anti-GHl’ serum cross-reacts with Hl” but 
does not cross-react with GHS, H5, Hl, GHl and 
core histones. These data imply that there must be 
an immunological determinant(s) in GHl’ which 
does not exist in GH 1, GHS, H 1 and H5. Although 
it is not clear which sequence or structure in GH lo 
is the immunological determinant which does not 
exist in GHS, this antiserum is very useful in deter- 
mining the existence of Hl” in organisms. 
3.2. Detection of an HI”-like protein in bullfrog 
erythrocyte 
Acid extractable nuclear proteins from bullfrog 
were transferred to nitrocellulose filter and reacted 
with anti-GHl” serum or anti-GH5 serum. The 
proteins of the Hl and H5 region of the gel are less 
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Fig.1. Reaction of anti-GHl” and anti-GH5 serum with Hl, HS, Hl”, GHl, GHl” and GHS. Purified Hl, Hl”, H5, 
GHl, GHl” and GHS were electrophoresed in SDS gels and transferred to nitrocellulose filter as described in section 
2. After staining with Amido black, the transferred proteins were incubated with indicated antisera (1:40 dilution), with 
1251-labelled protein A and autoradiographed by use of Kodak XAR-5 or XS-5 film. (1) H5 and GH5 (chicken 
erythrocyte), (2) Hl” and GHl” (beef liver), (3) Hl and GHl (beef liver). (A) Protein transferred to nitrocellulose filter 
from SDS gel and stained with Amido black. Autoradiography: (B) Reaction with anti-GH5 serum (serum also reacted 
with degraded H5 molecule, lane 1). (C) Reaction with anti-Hl” serum. 
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Fig.2. The existence of the Hl “-like protein in bullfrog erythrocyte. The histones from chicken erythrocytes (l), bullfrog 
erythrocytes (2) and HI/HI’ from beef liver (3) were electrophoresed and processed for immunoblotting with anti-Hl” 
and anti-H5 serum as described for fig.1. (A) Proteins transferred to nitrocellulose filter, stained with Amido-black. 
Autoradiography: (B) Reacted with anti-GHS serum. The band above HS shown in (1) was a slower migrating protein 
than Hl. (C) Reacted with anti-GHl” serum. 
H5- -HI’ 
- H1° 
clear with bullfrog than with chicken erythrocyte, 
probably due to contaminating proteins. However, 
anti-GHS serum did not react with any proteins 
from bullfrog while anti-GHl o serum reacted with 
one of these proteins (fig.2). The &value of this 
protein is a little higher than HI0 of mammalian 
cells as determined by SDS-gel electrophoresis. 
This result shows that this protein has an im- 
munogenic determinant(s) in common with GHl” 
but does not have any determinants of GH5. This 
protein is not identical with mammalian Hl” and 
can be called an Hl”-like protein as reported 
earlier. 
When the injection was continued after the anti- 
GHl o serum reported here was obtained, this rab- 
bit developed anti-GH lo serum which reacted both 
with GHl” and GHS. The separation of anti- 
GHl’ antibody from anti-GHS antibody is pro- 
ceeding now in our laboratory. Recently, by use of 
this serum, an Hl”-like protein was detected in 
chromosomal proteins of the slime mold 
Physarum polycephalum (in preparation). This 
anti-GHl ’ serum seems to be very useful to 
distinguish Hl “-like proteins (or Hl”) from 
HS-like proteins (or H5). 
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